MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera, or Guardian 4, and wraparound applications and services. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.
| Business Activity | PASS |
| Debt Ratio | N/A |
| Cash Ratio | N/A |
| Receivables Ratio | N/A |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
$3.3B
0.93
12
$3.0B
$61.0M
1.31
6.04
0.2%
8,000
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($21.67, 12 analysts) | |||
| 10 | $108.00 | +$108.70 (101%) | 6.7R |
| 50 | $540.00 | +$543.50 (101%) | 6.7R |
| 100 | $1,080.00 | +$1,087.00 (101%) | 6.7R |
- Elevated short interest (6.04 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.